2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman, +32

Arthritis & Rheumatism

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt, +14

New England Journal of Medicine

Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer

David Cunningham, Yves Humblet, Salvatore Siena, +9

New England Journal of Medicine

Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer

Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre, +14

New England Journal of Medicine

Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer

Jan B. Vermorken, Fernando Rivera, Éva Remenár, +14

New England Journal of Medicine

Meta-analyses involving cross-over trials: methodological issues

Diana R Elbourne, Douglas G. Altman, Julian P. T. Higgins, +3

International Journal of Epidemiology

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Robert Pirker, Jose R. Pereira, Aleksandra Szczęsna, +15

The Lancet

MedicineMetronomic TherapyPhase Iii TrialBronchial NeoplasmCancer Treatment +5

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

Howard L. Kaufman, Jeffery S. Russell, Omid Hamid, +15

The Lancet Oncology

MedicineMetronomic TherapyPathologyCancer TreatmentOncology +1

Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial

Roger Stupp, Monika E. Hegi, Thierry Gorlia, +33

The Lancet Oncology

Neuro-oncologyGliomaMedicineStandard TreatmentPathology +7

NCCN Guidelines Insights: Colon Cancer, Version 2.2018

Al B. Benson, Alan P. Venook, Mahmoud M. Al-Hawary, +33

Journal of the National Comprehensive Cancer Network